Antibodies to infliximab in patients with Crohn's disease do not cross-react with certolizumab pegol

被引：0
|
作者：
Vetterlein, O. [1 ]
Kopotsha, T. M. [1 ]
Nesbitt, A. M. [1 ]
Brown, D. T. [1 ]
Stephens, S. [1 ]
机构：
[1] Celltech Antibody Ctr Excellence, Antibody Biol Div, Slough, Berks, England
来源：
GUT | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
356
引用
收藏
页码：A116 / A116
页数：1
相关论文
共 50 条
  • [31] Certolizumab Pegol Effectiveness in Crohn's Disease Patients with Secondary Failure to Infliximab Is Independent of Infliximab Dosing: Results from the WELCOME Study
    Abreu, Maria T.
    Vermeire, Severine
    Rutgeerts, Paul J.
    Ullman, Thomas A.
    Wolf, Douglas C.
    Sandborn, William J.
    GASTROENTEROLOGY, 2009, 136 (05) : A181 - A181
  • [32] Certolizumab Pegol for the Management of Crohn's Disease in Adults
    Rivkin, Anastasia
    CLINICAL THERAPEUTICS, 2009, 31 (06) : 1158 - 1176
  • [33] Pharmakokinetics of Certolizumab Pegol Induction in Crohn's Disease
    Wolf, Douglas C.
    Wolf, Christine
    GASTROENTEROLOGY, 2015, 148 (04) : S867 - S868
  • [34] Efficacy of certolizumab pegol is not affected by baseline anti-infliximab antibody status in patients with Crohn's disease with secondary infliximab failure
    Sandborn, W.
    Vermeire, S.
    D'Haens, G.
    Colombel, J.
    Fedorak, R.
    Spehlmann, M.
    Wolf, D.
    Mitchev, K.
    Jamoul, C.
    Abreu, M.
    Rutgeerts, P.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S13 - S14
  • [35] Maintenance therapy with certolizumab pegol for Crohn's disease
    Schreiber, Stefan
    Khaliq-Kareemi, Mani
    Lawrance, Ian C.
    Thomsen, Ole Ostergaard
    Hanauer, Stephen B.
    McColm, Juliet
    Bloomfield, Ralph
    Sandborn, William J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (03): : 239 - 250
  • [36] Certolizumab pegol for induction of remission in Crohn's disease
    Yamazaki, Hajime
    So, Ryuhei
    Matsuoka, Katsuyoshi
    Kobayashi, Taku
    Shinzaki, Shinichiro
    Matsuura, Minoru
    Okabayashi, Shinji
    Kataoka, Yuki
    Tsujimoto, Yasushi
    Furukawa, Toshi A.
    Watanabe, Norio
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (08):
  • [37] Certolizumab pegol in treatment of Crohn's disease with perianal lesions
    Khalif, I. L.
    Nanaeva, B. A.
    Shapina, M., V
    Vardanyan, A. V.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (04) : 50 - 54
  • [38] Severe Crohn's disease symptoms are relieved by certolizumab pegol
    Feagan, Brian G.
    Coteur, Geoffroy
    Keininger, Doroth L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S471 - S471
  • [39] Certolizumab pegol: A guide to its use in Crohn's disease
    不详
    Drugs & Therapy Perspectives, 2007, 23 (11) : 5 - 8
  • [40] Successful treatment of fistulizing Crohn's disease with certolizumab pegol
    Danese, Silvio
    Stefanelli, Tommaso
    Omodei, Paolo
    Zatelli, Stefania
    Bonifacio, Cristiana
    Balzarini, Luca
    Repici, Alessandro
    Malesci, Alberto
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (02) : 292 - 293
12345